Nuvaco


Film-coated tablets
scheduling status
S4
registration number
52/20.2.8/0949
What Nuvaco contains
Each NUVACO film-coated tablet contains: Lamivudine 300 mg, Tenofovir disoproxil fumarate 300 mg, Dolutegravir sodium equivalent to Dolutegravir 50 mg.
other ingredients
Tablet core: Croscarmellose sodium, Hydroxypropyl cellulose, Magnesium stearate, Mannitol, Microcrystalline cellulose, Povidone, Sodium starch glycolate, Sodium stearyl fumarate. Film coating: Iron oxide red (E172), Iron oxide yellow (E172, Macrogol/polyethylene glycol (E1521), Polyvinyl alcohol (E1203), Talc (E553b), Titanium dioxide (E171).
Therapeutic classification
J05AR27 Antivirals for treatment of HIV infections, combinations.
© 2026 SAHPRA. ALL RIGHTS RESERVED